BG
CYTK icon

BlackRock Group’s Cytokinetics CYTK Stock Holding History

BlackRock Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-11,656
Closed -$111K – 2990
2016
Q2 		$111K Hold
11,656
– – ﹤0.01% 2765
2016
Q1 		$82K Hold
11,656
– – ﹤0.01% 2813
2015
Q4 		$122K Sell
11,656
-10,318
-47% -$101K ﹤0.01% 2624
2015
Q3 		$147K Buy
+21,974
New +$150K ﹤0.01% 2605
2014
Q4 		– Sell
-6,370
Closed -$22K – 2878
2014
Q3 		$22K Hold
6,370
– – ﹤0.01% 2751
2014
Q2 		$30K Buy
+6,370
New +$38.9K ﹤0.01% 2746

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock Group's CYTK Position: Q3 2016 in Review

BlackRock Group sold out of Cytokinetics (CYTK) in Q3 2016, closing a stake of 11,656 shares — an estimated $111K sold.

BlackRock Group first reported a position in CYTK in Q2 2014 and held it in 6 quarters. The position peaked at $147K in Q3 2015. 91 funds tracked by Wall St. Rank hold CYTK as of Q3 2016.

  • BlackRock Group reported no remaining Cytokinetics position as of Q3 2016 after selling out during the quarter.
  • BlackRock Group sold 11,656 Cytokinetics shares in Q3 2016, an estimated $111K.
  • BlackRock Group first reported a position in Cytokinetics in Q2 2014 and held it in 6 quarters.
  • BlackRock Group's Cytokinetics position peaked at $147K in Q3 2015.
  • 91 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2016.

Based on BlackRock Group's 13F filing for Q3 2016, filed 8 Nov 2016.